Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 1201 AL 1215

A Review on Recent Approaches on Molecular Docking Studies of Novel Compounds Targeting Acetylcholinesterase in Alzheimer Disease

Peitzika SC, Pontiki E.

Molecules. 2023 Jan 21;28(3):1084. doi: 10.3390/molecules28031084.

Anti-Neuroinflammatory Potential of Natural Products in the Treatment of Alzheimer's Disease

Deng M, Yan W, Gu Z, Li Y, Chen L, He B.

Molecules. 2023 Feb 3;28(3):1486. doi: 10.3390/molecules28031486.

Aducanumab for the treatment of Alzheimer's disease: a systematic review

Rahman A, Hossen MA, Chowdhury MFI, Bari S, Tamanna N, Sultana SS, Haque SN, Al Masud A, Saif-Ur-Rahman KM.

Psychogeriatrics. 2023 May;23(3):512-522. doi: 10.1111/psyg.12944. Epub 2023 Feb 12.

Elucidating the promising role of traditional Chinese medicine in neuroprotection against oxidative stress encompassing Alzheimer's disease

Arora A, Behl T, Sehgal A, Singh S, Sharma N, Abdellatif AAH, Dailah HG, Bhatia S, Al-Harrasi A, Aleya L, Bungau S.

Environ Sci Pollut Res Int. 2023 Mar;30(14):39546-39557. doi: 10.1007/s11356-023-25800-4. Epub 2023 Feb 15.

Guiding safer risperidone prescribing in Alzheimer's disease with therapeutic drug monitoring

Roughley M, Mena C, Howard R, Reeves S, Bertrand J.

Br J Clin Pharmacol. 2023 Jul;89(7):2316-2321. doi: 10.1111/bcp.15692. Epub 2023 Feb 28.

Herbal Therapeutics for Alzheimer's Disease: Ancient Indian Medicine System from the Modern Viewpoint

Kushwah S, Maurya NS, Kushwaha S, Scotti L, Chawade A, Mani A.

Curr Neuropharmacol. 2023;21(4):764-776. doi: 10.2174/1570159X21666230216094353.

Safety, tolerability, and pharmacokinetics of fluoropezil (DC20), a novel acetylcholinesterase inhibitor: A phase I study in healthy young and elderly Chinese subjects

Qian H, Yu C, Zhu H, Ding Q, Cai Y, Jing J, Xu X, Guo R, Zhang H, Liu H, Chen X, Liu Y.

Clin Transl Sci. 2023 May;16(5):810-822. doi: 10.1111/cts.13490. Epub 2023 Feb 26.

Mechanistic and therapeutic role of NLRP3 inflammasome in the pathogenesis of Alzheimer's disease

Jha D, Bakker ENTP, Kumar R.

J Neurochem. 2024 Oct;168(10):3574-3598. doi: 10.1111/jnc.15788. Epub 2023 Mar 9.

Extemporaneous combination of donepezil and memantine to treat dementia in Alzheimer disease: evidence from Italian real-world data

Padovani A, Falato S, Pegoraro V.

Curr Med Res Opin. 2023 Apr;39(4):567-577. doi: 10.1080/03007995.2023.2182530. Epub 2023 Mar 11.

Research progress of natural products and their derivatives against Alzheimer's disease

Liu JY, Guo HY, Quan ZS, Shen QK, Cui H, Li X.

J Enzyme Inhib Med Chem. 2023 Dec;38(1):2171026. doi: 10.1080/14756366.2023.2171026.

Donanemab Population Pharmacokinetics, Amyloid Plaque Reduction, and Safety in Participants with Alzheimer's Disease

Gueorguieva I, Willis BA, Chua L, Chow K, Ernest CS, Shcherbinin S, Ardayfio P, Mullins GR, Sims JR.

Clin Pharmacol Ther. 2023 Jun;113(6):1258-1267. doi: 10.1002/cpt.2875. Epub 2023 Mar 9.

Aberrant protein S-nitrosylation contributes to hyperexcitability-induced synaptic damage in Alzheimer's disease: Mechanistic insights and potential therapies

Ghatak S, Nakamura T, Lipton SA.

Front Neural Circuits. 2023 Feb 2;17:1099467. doi: 10.3389/fncir.2023.1099467. eCollection 2023.

The Sensitivity of Tau Tracers for the Discrimination of Alzheimer's Disease Patients and Healthy Controls by PET

Mohammadi Z, Alizadeh H, Marton J, Cumming P.

Biomolecules. 2023 Feb 3;13(2):290. doi: 10.3390/biom13020290.

Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders

Nirogi R, Jayarajan P, Shinde A, Mohammed AR, Grandhi VR, Benade V, Goyal VK, Abraham R, Jasti V, Cummings J.

Biomolecules. 2023 Feb 7;13(2):309. doi: 10.3390/biom13020309.

The Amyloid-Beta Clearance: From Molecular Targets to Glial and Neural Cells

Cai W, Wu T, Chen N.

Biomolecules. 2023 Feb 7;13(2):313. doi: 10.3390/biom13020313.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias